Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 
WOBURN, Mass., Oct. 17, 2016 -- Metabolix, Inc. (NASDAQ:MBLX), announced today that the Company will host a conference call and live webcast on Thursday, October 20 to provide an investor presentation on the mission, vision and technology platform of Yield10 Bioscience. Metabolix recently announced that Yield10 is becoming its core business with a focus on developing disruptive technologies for step-change improvements to crop yield to enhance global food security.
Metabolix invites shareholders to submit questions for consideration to [email protected] with the subject line: “Questions for Yield10 Call.” Questions submitted in advance of the call will be reviewed and certain of them may be addressed in management's prepared remarks or in the Q&A portion of the call.
Conference Call Information
Company management will host a conference call Thursday, October 20, 2016 at 4:30 p.m. (ET) to provide an investor presentation on Yield10 Bioscience. A live webcast of the call including the slide deck can be accessed through the Company’s website at http://www.metabolix.com in the investor relations section. To participate in the call, dial toll-free 877-709-8150 or 201-689-8354 (international).
To listen to a telephonic replay of the conference call, dial toll-free 877-660-6853 or 201-612-7415 (international) and enter pass code 13648035. The replay will be available for 14 days. In addition, the webcast will be archived on the Company’s website in the investor relations section.
About Metabolix
Metabolix, Inc. is winding down its legacy PHA biopolymer business and becoming Yield10 Bioscience. Yield10 is leveraging Metabolix’s extensive track record of innovation based around optimizing the flow of carbon intermediates in living systems with a focus on developing disruptive technologies for step-change improvements in crop yield. Yield10 is working on new approaches to improve fundamental elements of plant metabolism through enhanced photosynthetic efficiency and directed carbon utilization. Yield10 is advancing the development of several yield traits in crops such as camelina, canola, soybean and corn. The Company is based in Woburn, MA.
For more information, visit www.metabolix.com. (MBLX-E)
For more information on Yield10 Bioscience, visit Yield10.
Metabolix Contact: Lynne H. Brum, 617-682-4693, [email protected]
